JP2676720B2 - Method for producing 1,5-benzothiazepine derivative - Google Patents
Method for producing 1,5-benzothiazepine derivativeInfo
- Publication number
- JP2676720B2 JP2676720B2 JP6181894A JP6181894A JP2676720B2 JP 2676720 B2 JP2676720 B2 JP 2676720B2 JP 6181894 A JP6181894 A JP 6181894A JP 6181894 A JP6181894 A JP 6181894A JP 2676720 B2 JP2676720 B2 JP 2676720B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- compound
- toluenesulfonic acid
- methoxyphenyl
- reflux temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、医薬化合物の合成中間
体として有用な1,5−ベンゾチアゼピン誘導体の製法
に関する。TECHNICAL FIELD The present invention relates to a process for producing a 1,5-benzothiazepine derivative useful as a synthetic intermediate for pharmaceutical compounds.
【0002】[0002]
【従来の技術】一般式(I)2. Description of the Related Art General formula (I)
【0003】[0003]
【化4】 Embedded image
【0004】(但し、Rは低級アルキル基を表す。)で
示される1,5−ベンゾチアゼピン誘導体は医薬化合
物、例えば優れた冠血管拡張作用を有する(+)−シス
−2−(4−メトキシフェニル)−3−アセトキシ−5
−(β−ジメチルアミノエチル)−2,3−ジヒドロ−
1,5−ベンゾチアゼピン−4(5H)−オン(一般
名:ジルチアゼム)の合成中間体として有用な化合物で
ある。The 1,5-benzothiazepine derivative represented by (wherein R represents a lower alkyl group) is a pharmaceutical compound such as (+)-cis-2- (4-) having an excellent coronary vasodilatory action. Methoxyphenyl) -3-acetoxy-5
-(Β-Dimethylaminoethyl) -2,3-dihydro-
It is a compound useful as a synthetic intermediate for 1,5-benzothiazepin-4 (5H) -one (generic name: diltiazem).
【0005】従来、1,5−ベンゾチアゼピン誘導体
(I)の製法としては、例えば2−ヒドロキシ−3−
(2−アミノフェニルチオ)−3−(4−メトキシフェ
ニル)プロピオン酸をキシレン中加熱還流して分子内閉
環する方法が知られている(特公昭53−1803
8)。しかしながら、この方法では反応完結に長時間
(上記公報の実施例では12時間)を要するという難点
があり、化合物(I)の工業的製法としては必ずしも満
足しうるものではなかった。Conventionally, as a method for producing the 1,5-benzothiazepine derivative (I), for example, 2-hydroxy-3-
A method is known in which (2-aminophenylthio) -3- (4-methoxyphenyl) propionic acid is heated and refluxed in xylene to perform intramolecular ring closure (Japanese Patent Publication No. 53-1803).
8). However, this method has a drawback that it takes a long time (12 hours in the examples of the above publications) to complete the reaction, and it is not always satisfactory as an industrial production method of the compound (I).
【0006】[0006]
【発明が解決しようとする課題】本発明は、優れた冠血
管拡張作用を有する医薬化合物の合成中間体である1,
5−ベンゾチアゼピン誘導体の製法を提供するものであ
る。DISCLOSURE OF THE INVENTION The present invention is a synthetic intermediate of a pharmaceutical compound having an excellent coronary vasodilator action 1,
A method for producing a 5-benzothiazepine derivative is provided.
【0007】[0007]
【課題を解決するための手段】本発明者らは種々研究を
重ねた結果、化合物(II)の分子内閉環反応を特定の
スルホン酸化合物の存在下に実施すれば、反応時間を著
しく短縮させることができ、しかも収率よく化合物
(I)を製造しうることを見い出し、本発明を完成する
に至った。Means for Solving the Problems As a result of various studies conducted by the present inventors, if the intramolecular ring-closing reaction of compound (II) is carried out in the presence of a specific sulfonic acid compound, the reaction time is significantly shortened. It was found that the compound (I) can be produced with good yield and the present invention was completed.
【0008】すなわち、本発明によれば、目的化合物
(I)は一般式(II)That is, according to the present invention, the target compound (I) is represented by the general formula (II)
【0009】[0009]
【化5】 Embedded image
【0010】(但し、Rは前記と同一意味を有する。)
で示されるプロピオン酸誘導体を、一般式(III)(However, R has the same meaning as described above.)
The propionic acid derivative represented by the general formula (III)
【0011】[0011]
【化6】 Embedded image
【0012】(但し、R1 は置換もしくは非置換フェニ
ル基を表す。)で示されるスルホン酸化合物の存在下、
分子内閉環反応に付すことにより製造することができる
(但し、前記分子内閉環反応を有機溶媒、例えば、ベン
ゼン、トルエン、またはより好ましくはキシレンの混合
物中で、溶媒のほぼ還流温度において、窒素を反応混合
物を通して泡立てて通入しながら、有機酸の触媒、例え
ば、p−トルエンスルホン酸一水和物の存在下で実施す
る場合、或いはキシレン中、還流温度においてアルゴン
雰囲気下、p−トルエンスルホン酸一水和物の存在下に
実施する場合を除く)。(Wherein R 1 represents a substituted or unsubstituted phenyl group),
It can be produced by subjecting it to an intramolecular ring closure reaction.
(However, if the intramolecular ring-closing reaction is carried out with an organic solvent such as benzene,
A mixture of zen, toluene, or more preferably xylene.
Reaction mixture with nitrogen at about the reflux temperature of the solvent
While bubbling through something, let's look at organic acid catalysts, for example
For example, in the presence of p-toluenesulfonic acid monohydrate
Argon in xylene at reflux temperature.
In the presence of p-toluenesulfonic acid monohydrate under an atmosphere
Except when implementing) .
【0013】本発明方法で使用するスルホン酸化合物
(III)としては、例えば一般式(III)において
R1がメチル基、エチル基、プロピル基又はブチル基の如
き炭素数1〜4のアルキル基で置換されていてもよいフ
ェニル基である化合物があげられる。これらのうち、よ
り好ましいものとしては、トルエンスルホン酸があげら
れる。本スルホン酸化合物の使用量は特に制限されない
が、通常化合物(II)に対し0.5〜10w/w%、
好ましくは1〜6w/w%程度の割合で用いるのがよ
い。Examples of the sulfonic acid compound (III) used in the method of the present invention include those represented by the general formula (III)
Examples thereof include compounds in which R 1 is a phenyl group which may be substituted with an alkyl group having 1 to 4 carbon atoms such as a methyl group, an ethyl group, a propyl group or a butyl group. Among these, toluenesulfonic acid is more preferable. The amount of the sulfonic acid compound used is not particularly limited, but is usually 0.5 to 10 w / w% with respect to the compound (II),
It is preferable to use it at a ratio of about 1 to 6 w / w%.
【0014】本反応は、例えばキシレン、トルエン、ジ
クロロベンゼン等の高沸点溶媒中加熱還流下に実施する
のが好ましい。This reaction is preferably carried out in a high boiling point solvent such as xylene, toluene, dichlorobenzene or the like under heating under reflux.
【0015】生成した目的化合物(I)は、例えば反応
液を冷却して析出する結晶をろ取し、適当な溶媒(例え
ば、エタノール、含水エタノール)で洗浄する如き簡易
な操作でスルホン酸化合物(III)を含まない純品と
して単離することができる。The desired compound (I) thus produced is subjected to a simple operation such as cooling the reaction solution, collecting the precipitated crystals by filtration, and washing with a suitable solvent (eg ethanol, hydrous ethanol). It can be isolated as a pure product without III).
【0016】実験例 (+)−スレオ−2−ヒドロキシ−3−(2−アミノフ
ェニルチオ)−3−(4−メトキシフェニル)プロピオ
ン酸12.75gをキシレン又はトルエン52ml中
で、生成する水を分離留去しながら加熱還流して(+)
−シス−2−(4−メトキシフェニル)−3−ヒドロキ
シ−2,3−ジヒドロ−1,5−ベンゾチアゼピン−4
(5H)−オンを生成させるに際し、反応系にスルホン
酸化合物を存在させた場合の効果を調べたところ、下記
第1表及び第2表に示す結果が得られた。Experimental Example 12.75 g of (+)-threo-2-hydroxy-3- (2-aminophenylthio) -3- (4-methoxyphenyl) propionic acid was dissolved in 52 ml of xylene or toluene to produce water. Heat to reflux while separating and evaporating (+)
-Cis-2- (4-methoxyphenyl) -3-hydroxy-2,3-dihydro-1,5-benzothiazepine-4
When the effect of the presence of a sulfonic acid compound in the reaction system in producing (5H) -one was examined, the results shown in Tables 1 and 2 below were obtained.
【0017】なお、表中使用量は原料化合物に対するス
ルホン酸化合物の使用量を表し、p−トルエンスルホン
酸は水和物として使用した。The amount used in the table represents the amount of the sulfonic acid compound used with respect to the raw material compound, and p-toluenesulfonic acid was used as a hydrate.
【0018】[0018]
【表1】 [Table 1]
【0019】[0019]
【表2】 [Table 2]
【0020】上記第1表及び第2表から、p−トルエン
スルホン酸を反応系に存在させておくことにより、極め
て短時間に収率よく目的物を得ることができることがわ
かる。From Tables 1 and 2 above, it can be seen that by allowing p-toluenesulfonic acid to be present in the reaction system, the desired product can be obtained in a very short time with good yield.
【0021】[0021]
実施例1 (+)−スレオ−2−ヒドロキシ−3−(2−アミノフ
ェニルチオ)−3−(4−メトキシフェニル)プロピオ
ン酸12.75g、p−トルエンスルホン酸水和物14
0mg及びキシレン52mlの混合物を約1時間15分
加熱還流する。Example 1 12.75 g of (+)-threo-2-hydroxy-3- (2-aminophenylthio) -3- (4-methoxyphenyl) propionic acid, p-toluenesulfonic acid hydrate 14
A mixture of 0 mg and xylene 52 ml is heated to reflux for about 1 hour and 15 minutes.
【0022】この間、反応で生成する水は分離留去す
る。冷却後析出結晶をろ取し、冷エタノールで洗浄後乾
燥して(+)−シス−2−(4−メトキシフェニル)−
3−ヒドロキシ−2,3−ジヒドロ−1,5−ベンゾチ
アゼピン−4(5H)−オン11.5gを得る。During this time, the water produced in the reaction is separated and distilled off. After cooling, the precipitated crystals were collected by filtration, washed with cold ethanol and dried (+)-cis-2- (4-methoxyphenyl)-.
11.5 g of 3-hydroxy-2,3-dihydro-1,5-benzothiazepin-4 (5H) -one are obtained.
【0023】収率:95.9% M.P.:203〜204℃ 〔α〕D 20:+116°(C=0.5、ジメチルホルム
アミド) 実施例2 (+)−スレオ−2−ヒドロキシ−3−(2−アミノフ
ェニルチオ)−3−(4−メトキシフェニル)プロピオ
ン酸12.75g、p−トルエンスルホン酸水和物69
0mg及びトルエン52mlの混合物を約5時間加熱還
流する。この間、反応で生成する水は分離留去する。冷
却後析出結晶をろ取し、冷エタノールで洗浄後乾燥して
(+)−シス−2−(4−メトキシフェニル)−3−ヒ
ドロキシ−2,3−ジヒドロ−1,5−ベンゾチアゼピ
ン−4(5H)−オン11gを得る。Yield: 95.9% M. P. : 203 to 204 ° C. [α] D 20 : + 116 ° (C = 0.5, dimethylformamide) Example 2 (+)-threo-2-hydroxy-3- (2-aminophenylthio) -3- (4 -Methoxyphenyl) propionic acid 12.75 g, p-toluenesulfonic acid hydrate 69
A mixture of 0 mg and 52 ml toluene is heated to reflux for about 5 hours. During this time, water generated in the reaction is separated and distilled off. After cooling, the precipitated crystals were collected by filtration, washed with cold ethanol and dried to obtain (+)-cis-2- (4-methoxyphenyl) -3-hydroxy-2,3-dihydro-1,5-benzothiazepine- 11 g of 4 (5H) -one are obtained.
【0024】収率:92% M.P.:203〜204.5℃ 〔α〕D 20:+118°(C=0.5、ジメチルホルム
アミド)Yield: 92% P. : 203 to 204.5 ° C. [α] D 20 : + 118 ° (C = 0.5, dimethylformamide)
【0025】[0025]
【発明の効果】本発明方法は、既知の方法に比べて分子
内閉環反応に要する時間を著しく短縮させることがで
き、しかも高収率で純度よく目的化合物を得ることがで
きるため、工業的製法として極めて優れた方法である。INDUSTRIAL APPLICABILITY The method of the present invention can significantly shorten the time required for the intramolecular ring closure reaction as compared with the known method, and can obtain the target compound with high yield and high purity. Is an extremely excellent method.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 北野 雅資 奈良県北▲葛▼城郡河合町久美ヶ丘1丁 目4番3 (72)発明者 前田 貞夫 大阪府茨木市水尾3丁目13−605号 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masashi Kitano North 4 Nara Prefecture ▲ Katsura ▼ 1-4-3 Kumigaoka, Kawai-cho, Castle-gun (72) Inventor Sadao Maeda 3- 13 Mizuo, Ibaraki-shi, Osaka No. 605
Claims (3)
ピオン酸誘導体を、一般式(III) 【化2】 (但し、R1は置換もしくは非置換フェニル基を表
す。)で示されるスルホン酸化合物の存在下、分子内閉
環反応に付し、所望により生成物をその塩とすることを
特徴とする一般式(I) 【化3】 (但し、Rは前記と同一意味を表す。)で示される1,
5−ベンゾチアゼピン誘導体又はその塩の製法(但し、
前記分子内閉環反応を有機溶媒、例えば、ベンゼン、ト
ルエン、またはより好ましくはキシレンの混合物中で、
溶媒のほぼ還流温度において、窒素を反応混合物を通し
て泡立てて通入しながら、有機酸の触媒、例えば、p−
トルエンスルホン酸一水和物の存在下で実施する場合、
或いはキシレン中、還流温度においてアルゴン雰囲気
下、p−トルエンスルホン酸一水和物の存在下に実施す
る場合を除く)。1. A compound represented by the general formula (II): (However, R represents a lower alkyl group.) The propionic acid derivative represented by the general formula (III): (Wherein R 1 represents a substituted or unsubstituted phenyl group), the compound is subjected to an intramolecular ring closure reaction in the presence of a sulfonic acid compound, and the product is converted to a salt thereof if desired. (I) (However, R represents the same meaning as described above.) 1,
Preparation of 5-benzothiazepine derivative or salt thereof (however,
The intramolecular ring closure reaction in an organic solvent such as benzene, toluene, or more preferably a mixture of xylenes,
At about the reflux temperature of the solvent, while bubbling nitrogen through the reaction mixture, the catalyst for the organic acid, eg p-
When carried out in the presence of toluenesulfonic acid monohydrate,
Alternatively, it is performed in xylene at reflux temperature under an argon atmosphere in the presence of p-toluenesulfonic acid monohydrate).
エンスルホン酸である請求項1記載の製法。2. The method according to claim 1, wherein the sulfonic acid compound (III) is p-toluenesulfonic acid.
(2−アミノフェニルチオ)−3−(4−メトキシフェ
ニル)プロピオン酸を一般式(III) 【化4】 (但し、R1は置換もしくは非置換フェニル基を表
す。)で示されるスルホン酸化合物の存在下、分子内閉
環反応に付し、得られた(+)−シス−2−(4−メト
キシフェニル)−3−ヒドロキシ−2,3−ジヒドロ−
1,5−ベンゾチアゼピン−4(5H)−オンの5位に
β−ジメチルアミノエチル基を導入する反応と3位ヒド
ロキシ基をアセチル化する反応を行い、所望により、生
成物を薬理的に許容しうる塩とすることにより、(+)
−シス−2−(4−メトキシフェニル)−3−アセトキ
シ−5−(β−ジメチルアミノエチル)−2,3−ジヒ
ドロ−1,5−ベンゾチアゼピン−4(5H)−オン又
はその薬理的に許容しうる塩に変換することを特徴とす
る1,5−ベンゾチアゼピン誘導体又はその塩の製法
(但し、前記分子内閉環反応を有機溶媒、例えば、ベン
ゼン、トルエン、またはより好ましくはキシレンの混合
物中で、溶媒のほぼ還流温度において、窒素を反応混合
物を通して泡立てて通入しながら、有機酸の触媒、例え
ば、p−トルエンスルホン酸一水和物の存在下で実施す
る場合、或いはキシレン中、還流温度においてアルゴン
雰囲気下、p−トルエンスルホン酸一水和物の存在下に
実施する場合を除く)。3. (+)-Threo-2-hydroxy-3-
(2-Aminophenylthio) -3- (4-methoxyphenyl) propionic acid has the general formula (III): (Wherein R 1 represents a substituted or unsubstituted phenyl group), and subjected to an intramolecular ring closure reaction in the presence of a sulfonic acid compound to obtain (+)-cis-2- (4-methoxyphenyl). ) -3-Hydroxy-2,3-dihydro-
At the 5-position of 1,5-benzothiazepin-4 (5H) -one
Reaction for introducing β-dimethylaminoethyl group and 3-position hydrid
Performs a reaction to acetylate the Roxy group, and if desired,
By converting the product into a pharmacologically acceptable salt , (+)
-Cis-2- (4-methoxyphenyl) -3-acetoxy-5- (β-dimethylaminoethyl) -2,3-dihydro-1,5-benzothiazepin-4 (5H) -one or pharmacologically A method for producing a 1,5-benzothiazepine derivative or a salt thereof, which comprises converting the intramolecular ring-closing reaction into an organic solvent such as benzene, toluene, or more preferably xylene. When carried out in the presence of a catalyst of an organic acid, for example p-toluenesulfonic acid monohydrate, with bubbling nitrogen through the reaction mixture at about the reflux temperature of the solvent in the mixture, or in xylene. , Except at the reflux temperature in the presence of p-toluenesulfonic acid monohydrate under an argon atmosphere).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6181894A JP2676720B2 (en) | 1994-03-31 | 1994-03-31 | Method for producing 1,5-benzothiazepine derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6181894A JP2676720B2 (en) | 1994-03-31 | 1994-03-31 | Method for producing 1,5-benzothiazepine derivative |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1109795A Division JPH0798813B2 (en) | 1989-04-28 | 1989-04-28 | Process for producing 1,5-benzothiazepine derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH072810A JPH072810A (en) | 1995-01-06 |
| JP2676720B2 true JP2676720B2 (en) | 1997-11-17 |
Family
ID=13182054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6181894A Expired - Lifetime JP2676720B2 (en) | 1994-03-31 | 1994-03-31 | Method for producing 1,5-benzothiazepine derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2676720B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5897848A (en) * | 1997-09-19 | 1999-04-27 | Learonal Inc. | Process for producing hypophosphite compounds |
-
1994
- 1994-03-31 JP JP6181894A patent/JP2676720B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH072810A (en) | 1995-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0798813B2 (en) | Process for producing 1,5-benzothiazepine derivative | |
| JPS61122281A (en) | 1,5-benzothiazepine derivative and preparation thereof | |
| JP2676720B2 (en) | Method for producing 1,5-benzothiazepine derivative | |
| KR970002465B1 (en) | Process for preparing 1,5-benzothiazepine derivatives | |
| RU2141957C1 (en) | Method of synthesis of 3-hydroxy-5-[2-(dimethylamino)-ethyl]- -2,3-dihydro-4-(methoxyphenyl)-1,5-benzothiazepine-4-(5h)-on'e method of synthesis of benzothiazepine derivatives, method of synthesis of cis-(+)-3-acetoxy-5-[2-(dimethylamino)-ethyl]- -2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-(5h)-on'e | |
| KR910002879B1 (en) | Method for preparing 1,5-benzothiazepine derivative | |
| JP2979240B2 (en) | Purification method of (2S, 3S) -2,3-dihydro-3-hydroxy-2- (4-methoxyphenyl) -1,5-benzothiazepin-4 (5H) -one | |
| CA2015182C (en) | Processes for preparing 1,5-benzothiazepine derivatives | |
| JPH04221376A (en) | Preparation of 1,5-benzothiazepine derivative, and new 1,5-benzothiazepine derivative | |
| SE505880C2 (en) | Process for the preparation of benzothiazepines by cyclization with phosphonic acids | |
| US5055575A (en) | Process for preparing 1,5-benzothiazepine derivatives | |
| JP2551375B2 (en) | Process for producing 1,5-benzothiazepine derivative | |
| JPH0533705B2 (en) | ||
| US5310904A (en) | Process for preparing optically active benzothiazepine compounds by asymmetric reduction | |
| EP0778273B1 (en) | Process for preparing optically active 3-hydroxy-1,5-benzothiazepine derivative and intermediate therefor | |
| JP2646521B2 (en) | Preparation of optically active benzothiazepines by asymmetric reduction method | |
| CA1337346C (en) | Process for preparing 1,5-benzothiazepine derivatives | |
| GB2154578A (en) | Novel 1,5-benzothiazepine derivatives and processes for preparing the same | |
| FI91965C (en) | Method for alkylating a phenolic hydroxy group of a 1,5-benzothiazepine derivative without racemization of the starting material | |
| JPH05202013A (en) | Preparation of 1,5-benzothiazepine derivative | |
| JPH0527629B2 (en) | ||
| NO172286B (en) | PROCEDURE FOR THE PREPARATION OF 1,5-BENZOTIAZEPINE DERIVATIVES | |
| HK1003789B (en) | Process for preparing 1,5-benzothiazepine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20080725 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080725 Year of fee payment: 11 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20080725 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20080725 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080725 Year of fee payment: 11 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080725 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20090725 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20090725 |